|
| Hyperactivated endolysosomal trafficking in melanoma |
|
https://doi.org/10.18632/oncotarget.3141
Direna Alonso-Curbelo, and Maria S. Soengas
|
| 2583-2584 |
|
| Aboutface on the metabolic side effects of rapamycin |
|
https://doi.org/10.18632/oncotarget.3354
Adam B. Salmon
|
| 2585-2586 |
|
| Antibiotics for cancer therapy |
|
https://doi.org/10.18632/oncotarget.3388
Richard G. Pestell, and Albert A. Rizvanov
|
| 2587-2588 |
|
| Cancer associated fibroblasts in hematological malignancies |
|
https://doi.org/10.18632/oncotarget.2661
Lizzia Raffaghello, Angelo Vacca, Vito Pistoia, and Domenico Ribatti
|
| 2589-2603 |
|
| Functional consequence of the METT1010I polymorphism in breast cancer |
|
https://doi.org/10.18632/oncotarget.3094
Shuying Liu, Funda Meric-Bernstam, Napa Parinyanitikul, Bailiang Wang, Agda K. Eterovic, Xiaofeng Zheng, Mihai Gagea, Mariana Chavez-MacGregor, Naoto T. Ueno, Xiudong Lei, Wanding Zhou, Lakshmy Nair, Debu Tripathy, Powel H. Brown, Gabriel N. Hortobagyi, Ken Chen, John Mendelsohn, Gordon B. Mills, and Ana M. Gonzalez-Angulo
|
| 2604-2614 |
|
| Tumortargeting Salmonella typhimurium A1R arrests growth of breastcancer brain metastasis |
|
https://doi.org/10.18632/oncotarget.2811
Yong Zhang, Shinji Miwa, Nan Zhang, Robert M. Hoffman, and Ming Zhao
|
| 2615-2622 |
|
| Identification of a new class of natural product MDM2 inhibitor: In vitro and in vivo antibreast cancer activities and target validation |
|
https://doi.org/10.18632/oncotarget.3098
Jiang-Jiang Qin, Wei Wang, Sukesh Voruganti, Hui Wang, Wei-Dong Zhang, and Ruiwen Zhang
|
| 2623-2640 |
|
| Age and metabolic risk factors associated with oxidatively damaged DNA in human peripheral blood mononuclear cells |
|
https://doi.org/10.18632/oncotarget.3202
Mille Løhr, Annie Jensen, Louise Eriksen, Morten Grønbæk, Steffen Loft, and Peter Møller
|
| 2641-2653 |
|
| ERp57 modulates STAT3 activity in radioresistant laryngeal cancer cells and serves as a prognostic marker for laryngeal cancer |
|
https://doi.org/10.18632/oncotarget.3042
Min Ho Choe, Joong Won Min, Hong Bae Jeon, Dong-Hyung Cho, Jeong Su Oh, Hyun Gyu Lee, Sang-Gu Hwang, Sungkwan An, Young-Hoon Han, and Jae-Sung Kim
|
| 2654-2666 |
|
| Upregulation of CDK9 kinase activity and Mcl1 stability contributes to the acquired resistance to cyclindependent kinase inhibitors in leukemia |
|
https://doi.org/10.18632/oncotarget.2096
Yuh-Ying Yeh, Rong Chen, Joshua Hessler, Emilia Mahoney, Amy M. Lehman, Nyla A. Heerema, Michael R. Grever, William Plunkett, John C. Byrd, and Amy J. Johnson
|
| 2667-2679 |
|
| CBX7 and HMGA1b proteins act in opposite way on the regulation of the SPP1 gene expression |
|
https://doi.org/10.18632/oncotarget.2777
Romina Sepe, Umberto Formisano, Antonella Federico, Floriana Forzati, André Uchimura Bastos, Daniela D’ Angelo, Nunzio Antonio Cacciola, Alfredo Fusco, and Pierlorenzo Pallante
|
| 2680-2692 |
|
| The translation inhibitor silvestrol exhibits direct antitumor activity while preserving innate and adaptive immunity against EBVdriven lymphoproliferative disease |
|
https://doi.org/10.18632/oncotarget.2098
John T. Patton, Mark E. Lustberg, Gerard Lozanski, Sabrina L. Garman, William H. Towns, Callie M. Drohan, Amy Lehman, Xiaoli Zhang, Brad Bolon, Li Pan, A. Douglas Kinghorn, Michael R. Grever, David M. Lucas, and Robert A. Baiocchi
|
| 2693-2708 |
|
| A microRNA1280/JAG2 network comprises a novel biological target in highrisk medulloblastoma |
|
https://doi.org/10.18632/oncotarget.2779
Fengfei Wang, Marc Remke, Kruttika Bhat, Eric T. Wong, Shuang Zhou, Vijay Ramaswamy, Adrian Dubuc, Ekokobe Fonkem, Saeed Salem, Hongbing Zhang, Tze-chen Hsieh, Stephen T. O'Rourke, Lizi Wu, David W. Li, Cynthia Hawkins, Isaac S. Kohane, Joseph M. Wu, Min Wu, Michael D. Taylor, and Erxi Wu
|
| 2709-2724 |
|
| The non glycanated endocan polypeptide slows tumor growth by inducing stromal inflammatory reaction |
|
https://doi.org/10.18632/oncotarget.2614
Hanane Yassine, Nathalie De Freitas Caires, Florence Depontieu, Arnaud Scherpereel, Ali Awad, Anne Tsicopoulos, Christophe Leboeuf, Anne Janin, Catherine Duez, Bogdan Grigoriu, and Philippe Lassalle
|
| 2725-2735 |
|
| Upregulation of miR328 and inhibition of CREBDNAbinding activity are critical for resveratrolmediated suppression of matrix metalloproteinase2 and subsequent metastatic ability in human osteosarcomas |
|
https://doi.org/10.18632/oncotarget.3088
Shun-Fa Yang, Wei-Jiunn Lee, Peng Tan, Chih-Hsin Tang, Michael Hsiao, Feng-Koo Hsieh, and Ming-Hsien Chien
|
| 2736-2753 |
|
| Mutational spectrum of adult TALL |
|
https://doi.org/10.18632/oncotarget.2218
Martin Neumann, Sebastian Vosberg, Cornelia Schlee, Sandra Heesch, Stefan Schwartz, Nicola Gökbuget, Dieter Hoelzer, Alexander Graf, Stefan Krebs, Isabelle Bartram, Helmut Blum, Monika Brüggemann, Jochen Hecht, Stefan K. Bohlander, Philipp A. Greif, and Claudia D. Baldus
|
| 2754-2766 |
|
| Reduction of miR29c enhances pancreatic cancer cell migration and stem celllike phenotype |
|
https://doi.org/10.18632/oncotarget.3089
Jianxin Jiang, Chao Yu, Meiyuan Chen, Hao Zhang, Se Tian, and Chengyi Sun
|
| 2767-2778 |
|
| Sema6A and Mical1 control cell growth and survival of BRAFV600E human melanoma cells |
|
https://doi.org/10.18632/oncotarget.2995
Rossella Loria, Giulia Bon, Valentina Perotti, Enzo Gallo, Ilaria Bersani, Paola Baldassari, Manuela Porru, Carlo Leonetti, Selene Di Carlo, Paolo Visca, Maria Felice Brizzi, Andrea Anichini, Roberta Mortarini, and Rita Falcioni
|
| 2779-2793 |
|
| Expression of the potential therapeutic target CXXC5 in primary acute myeloid leukemia cells high expression is associated with adverse prognosis as well as altered intracellular signaling and transcriptional regulation |
|
https://doi.org/10.18632/oncotarget.3056
Øystein Bruserud, Håkon Reikvam, Hanne Fredly, Jørn Skavland, Karen-Marie Hagen, Tuyen Thy van Hoang, Annette K. Brenner, Amir Kadi, Audrey Astori, Bjørn Tore Gjertsen, and Frederic Pendino
|
| 2794-2811 |
|
| Novel antigens in nonsmall cell lung cancer: SP17 AKAP4 and PTTG1 are potential immunotherapeutic targets |
|
https://doi.org/10.18632/oncotarget.2802
Leonardo Mirandola, Jose A. Figueroa, Tam T. Phan, Fabio Grizzi, Minji Kim, Rakhshanda Layeequr Rahman, Marjorie R. Jenkins, Everardo Cobos, Cynthia Jumper, Raed Alalawi, and Maurizio Chiriva-Internati
|
| 2812-2826 |
|
| Folatemediated mitochondrial targeting with doxorubicinpolyrotaxane nanoparticles overcomes multidrug resistance |
|
https://doi.org/10.18632/oncotarget.3090
He Wang, Henghui Yin, Fengjiao Yan, Mingna Sun, Lingran Du, Wei Peng, Qiuli Li, Yinghong Feng, and Yi Zhou
|
| 2827-2842 |
|
| MicroRNA 196B regulates FASmediated apoptosis in colorectal cancer cells |
|
https://doi.org/10.18632/oncotarget.3066
Ji-Su Mo, Khondoker Jahengir Alam, In-Hong Kang, Won Cheol Park, Geom-Seog Seo, Suck-Chei Choi, Hun-Soo Kim, Hyung-Bae Moon, Ki-Jung Yun, and Soo-Cheon Chae
|
| 2843-2855 |
|
| Chronic inflammationrelated DNA damage response: a driving force of gastric cardia carcinogenesis |
|
https://doi.org/10.18632/oncotarget.3091
Runhua Lin, Dejun Xiao, Yi Guo, Dongping Tian, Hailong Yun, Donglin Chen, and Min Su
|
| 2856-2864 |
|
| NCL1 a highly selective lysinespecific demethylase 1 inhibitor suppresses prostate cancer without adverse effect |
|
https://doi.org/10.18632/oncotarget.3067
Toshiki Etani, Takayoshi Suzuki, Taku Naiki, Aya Naiki-Ito, Ryosuke Ando, Keitaro Iida, Noriyasu Kawai, Keiichi Tozawa, Naoki Miyata, Kenjiro Kohri, and Satoru Takahashi
|
| 2865-2878 |
|
| 12/15 lipoxygenase regulation of colorectal tumorigenesis is determined by the relative tumor levels of its metabolite 12HETE and 13HODE in animal models |
|
https://doi.org/10.18632/oncotarget.2994
Jian Chang, Li Jiang, Yinqiu Wang, Bing Yao, Shilin Yang, Bixiang Zhang, and Ming-Zhi Zhang
|
| 2879-2888 |
|
| Statininduced depletion of geranylgeranyl pyrophosphate inhibits cell proliferation by a novel pathway of Skp2 degradation |
|
https://doi.org/10.18632/oncotarget.3068
Jonathan Vosper, Alessia Masuccio, Michael Kullmann, Christian Ploner, Stephan Geley, and Ludger Hengst
|
| 2889-2902 |
|
| Clusterin facilitates metastasis by EIF3I/Akt/MMP13 signaling in hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.3093
Cun Wang, Guangzhi Jin, Haojie Jin, Ning Wang, Qin Luo, Yurong Zhang, Dongmei Gao, Kai Jiang, Dishui Gu, Qiujing Shen, Xisong Huo, Fangyuan Hu, Tianxiang Ge, Fangyu Zhao, Wei Chu, Huiqun Shu, Ming Yao, Wenming Cong, and Wenxin Qin
|
| 2903-2916 |
|
| Downregulation of G9a triggers DNA damage response and inhibits colorectal cancer cells proliferation |
|
https://doi.org/10.18632/oncotarget.2784
Jie Zhang, Pengxing He, Yong Xi, Meiyu Geng, Yi Chen, and Jian Ding
|
| 2917-2927 |
|
| Epigenetic reprogramming by tumorderived EZH2 gainoffunction mutations promotes aggressive 3D cell morphologies and enhances melanoma tumor growth |
|
https://doi.org/10.18632/oncotarget.2758
Anthony M. Barsotti, Michael Ryskin, Wenyan Zhong, Wei-Guo Zhang, Andreas Giannakou, Christine Loreth, Veronica Diesl, Maximillian Follettie, Jonathan Golas, Michelle Lee, Timothy Nichols, Conglin Fan, Gang Li, Stephen Dann, Valeria R. Fantin, Kim Arndt, Dominique Verhelle, and Robert A. Rollins
|
| 2928-2938 |
|
| Cathelicidin an antimicrobial peptide produced by macrophages promotes colon cancer by activating the Wnt/βcatenin pathway |
|
https://doi.org/10.18632/oncotarget.2845
Dong Li, Wenfan Liu, Xuan Wang, Junlu Wu, Wenqiang Quan, Yiwen Yao, Robert Bals, Shurong Ji, Kaiyin Wu, Jia Guo, and Haiying Wan
|
| 2939-2950 |
|
| Adhesion glycoprotein CD44 functions as an upstream regulator of a network connecting ERK AKT and HippoYAP pathways in cancer progression |
|
https://doi.org/10.18632/oncotarget.3095
Shiyi Yu, Xiuxiu Cai, Chenxi Wu, Lele Wu, Yuzhi Wang, Yan Liu, Zhenghong Yu, Sheng Qin, Fei Ma, Jean Paul Thiery, and Liming Chen
|
| 2951-2965 |
|
| miR638 promotes melanoma metastasis and protects melanoma cells from apoptosis and autophagy |
|
https://doi.org/10.18632/oncotarget.3070
Animesh Bhattacharya, Ulf Schmitz, Yvonne Raatz, Madeleine Schönherr, Tina Kottek, Marianne Schauer, Sandra Franz, Anja Saalbach, Ulf Anderegg, Olaf Wolkenhauer, Dirk Schadendorf, Jan C. Simon, Thomas Magin, Julio Vera, and Manfred Kunz
|
| 2966-2980 |
|
| Active secretion of CXCL10 and CCL5 from colorectal cancer microenvironments associates with GranzymeB+ CD8+ Tcell infiltration |
|
https://doi.org/10.18632/oncotarget.3205
Timothy J. Zumwalt, Mildred Arnold, Ajay Goel, and C. Richard Boland
|
| 2981-2991 |
|
| Transcriptional regulation of Sox2 by the retinoblastoma family of pocket proteins |
|
https://doi.org/10.18632/oncotarget.2996
Jéssica M. Vilas, Alba Ferreirós, Carmen Carneiro, Lluis Morey, Sabela Da Silva-Ãlvarez, Tânia Fernandes, MarÃa Abad, Luciano Di Croce, Tomás GarcÃa-Caballero, Manuel Serrano, Carmen Rivas, Anxo Vidal, and Manuel Collado
|
| 2992-3002 |
|
| TXNIP interaction with the Her1/2 pathway contributes to overall survival in breast cancer |
|
https://doi.org/10.18632/oncotarget.3096
Weiwei Nie, Weisun Huang, Wenwen Zhang, Jing Xu, Wei Song, Yanru Wang, Aiyu Zhu, Jiayan Luo, Guichun Huang, Yucai Wang, and Xiaoxiang Guan
|
| 3003-3012 |
|
| Protein arginine methyltransferase 7 promotes breast cancer cell invasion through the induction of MMP9 expression |
|
https://doi.org/10.18632/oncotarget.3072
R. Mitchell Baldwin, Nasim Haghandish, Manijeh Daneshmand, Shahrier Amin, Geneviève Paris, Theresa J. Falls, John C. Bell, Shahidul Islam, and Jocelyn Côté
|
| 3013-3032 |
|
| Cyclin alterations in diverse cancers: Outcome and coamplification network |
|
https://doi.org/10.18632/oncotarget.2848
Maria Schwaederle, Gregory A. Daniels, David E. Piccioni, Paul T. Fanta, Richard B. Schwab, Kelly A. Shimabukuro, Barbara A. Parker, and Razelle Kurzrock
|
| 3033-3042 |
|
| Sunitinib prevents cachexia and prolongs survival of mice bearing renal cancer by restraining STAT3 and MuRF1 activation in muscle |
|
https://doi.org/10.18632/oncotarget.2812
Francesca Pretto, Carmen Ghilardi, Michele Moschetta, Andrea Bassi, Alessandra Rovida, Valentina Scarlato, Laura Talamini, Fabio Fiordaliso, Cinzia Bisighini, Giovanna Damia, Maria Rosa Bani, Rosanna Piccirillo, and Raffaella Giavazzi
|
| 3043-3054 |
|
| Lovastatin enhances adenovirusmediated TRAIL induced apoptosis by depleting cholesterol of lipid rafts and affecting CAR and death receptor expression of prostate cancer cells |
|
https://doi.org/10.18632/oncotarget.3073
Youhong Liu, Lin Chen, Zhicheng Gong, Liangfang Shen, Chinghai Kao, Janet M. Hock, Lunquan Sun, and Xiong Li
|
| 3055-3070 |
|
| Longterm treatment with imatinib results in profound mast cell deficiency in Ph+ chronic myeloid leukemia |
|
https://doi.org/10.18632/oncotarget.3074
Sabine Cerny-Reiterer, Anja Rabenhorst, Gabriele Stefanzl, Susanne Herndlhofer, Gregor Hoermann, Leonhard Müllauer, Sigrid Baumgartner, Christine Beham-Schmid, Wolfgang R. Sperr, Christine Mannhalter, Heinz Sill, Werner Linkesch, Michel Arock, Karin Hartmann, and Peter Valent
|
| 3071-3084 |
|
| Paracrine SDF1α signaling mediates the effects of PSCs on GEM chemoresistance through an IL6 autocrine loop in pancreatic cancer cells |
|
https://doi.org/10.18632/oncotarget.3099
Hui Zhang, Huanwen Wu, Jian Guan, Li Wang, Xinyu Ren, Xiaohua Shi, Zhiyong Liang, and Tonghua Liu
|
| 3085-3097 |
|
| Molecular chaperone GRP78 enhances aggresome delivery to autophagosomes to promote drug resistance in multiple myeloma |
|
https://doi.org/10.18632/oncotarget.3075
Mohamed A.Y. Abdel Malek, Sajjeev Jagannathan, Ehsan Malek, Douaa M. Sayed, Sahar A. Elgammal, Hanan G. Abd El-Azeem, Nabila M. Thabet, and James J. Driscoll
|
| 3098-3110 |
|
| Galectin1 is overexpressed in CD133+ human lung adenocarcinoma cells and promotes their growth and invasiveness |
|
https://doi.org/10.18632/oncotarget.3076
Xuefeng Zhou, Dan Li, Xianguo Wang, Bo Zhang, Hua Zhu, and Jinping Zhao
|
| 3111-3122 |
|
| Slit2/Robo1 signaling promotes intestinal tumorigenesis through Srcmediated activation of the Wnt/βcatenin pathway |
|
https://doi.org/10.18632/oncotarget.3060
Qian-Qian Zhang, Da-lei Zhou, Yan Lei, Li Zheng, Sheng-Xia Chen, Hong-Ju Gou, Qu-Liang Gu, Xiao-Dong He, Tian Lan, Cui-Ling Qi, Jiang-Chao Li, Yan-Qing Ding, Liang Qiao, and Li-Jing Wang
|
| 3123-3135 |
|
| Top2a identifies and provides epigenetic rationale for novel combination therapeutic strategies for aggressive prostate cancer |
|
https://doi.org/10.18632/oncotarget.3077
Jason S. Kirk, Kevin Schaarschuch, Zafardjan Dalimov, Elena Lasorsa, ShengYu Ku, Swathi Ramakrishnan, Qiang Hu, Gissou Azabdaftari, Jianmin Wang, Roberto Pili, and Leigh Ellis
|
| 3136-3146 |
|
| Targeting miR381NEFL axis sensitizes glioblastoma cells to temozolomide by regulating stemness factors and multidrug resistance factors |
|
https://doi.org/10.18632/oncotarget.3061
Zeyou Wang, Jing Yang, Gang Xu, Wei Wang, Changhong Liu, Honghui Yang, Zhibin Yu, Qianqian Lei, Lan Xiao, Jing Xiong, Liang Zeng, Juanjuan Xiang, Jian Ma, Guiyuan Li, and Minghua Wu
|
| 3147-3164 |
|
| Disrupting LIN28 in atypical teratoid rhabdoid tumors reveals the importance of the mitogen activated protein kinase pathway as a therapeutic target |
|
https://doi.org/10.18632/oncotarget.3078
Melanie F. Weingart, Jacquelyn J. Roth, Marianne Hutt-Cabezas, Tracy M. Busse, Harpreet Kaur, Antoinette Price, Rachael Maynard, Jeffrey Rubens, Isabella Taylor, Xing-gang Mao, Jingying Xu, Yasumichi Kuwahara, Sariah J. Allen, Anat Erdreich-Epstein, Bernard E. Weissman, Brent A. Orr, Charles G. Eberhart, Jaclyn A. Biegel, and Eric H. Raabe
|
| 3165-3177 |
|
| Metformin inhibits tumor growth by regulating multiple miRNAs in human cholangiocarcinoma |
|
https://doi.org/10.18632/oncotarget.3063
Xingming Jiang, Ning Ma, Dayong Wang, Fuyuan Li, Rongzhang He, Dongliang Li, Ruiqi Zhao, Qingxin Zhou, Yimin Wang, Fumin Zhang, Ming Wan, Pengcheng Kang, Xu Gao, and Yunfu Cui
|
| 3178-3194 |
|
| Simultaneous targeting of androgen receptor AR and MAPKinteracting kinases MNKs by novel retinamides inhibits growth of human prostate cancer cell lines |
|
https://doi.org/10.18632/oncotarget.3084
Vidya P. Ramamurthy, Senthilmurugan Ramalingam, Lalji Gediya, Andrew K. Kwegyir-Afful, and Vincent C.O. Njar
|
| 3195-3210 |
|
| MicroRNA93 activates cMet/PI3K/Akt pathway activity in hepatocellular carcinoma by directly inhibiting PTEN and CDKN1A |
|
https://doi.org/10.18632/oncotarget.3085
Katsuya Ohta, Hiromitsu Hoshino, Jinhua Wang, Shigeshi Ono, Yuuki Iida, Keisuke Hata, Sharon K. Huang, Steven Colquhoun, and Dave S. B. Hoon
|
| 3211-3224 |
|
| Genistein suppresses FLT4 and inhibits human colorectal cancer metastasis |
|
https://doi.org/10.18632/oncotarget.3064
Xiao Xiao, Zhiguo Liu, Rui Wang, Jiayin Wang, Song Zhang, Xiqiang Cai, Kaichun Wu, Raymond C. Bergan, Li Xu, and Daiming Fan
|
| 3225-3239 |
|
| KITENIN promotes glioma invasiveness and progression associated with the induction of EMT and stemness markers |
|
https://doi.org/10.18632/oncotarget.3087
Kyung-Hwa Lee, Eun-Jung Ahn, Se-Jeong Oh, Ok Kim, Young-Eun Joo, Jeong-A Bae, Somy Yoon, Hyang-Hwa Ryu, Shin Jung, Kyung-Keun Kim, Jae-Hyuk Lee, and Kyung-Sub Moon
|
| 3240-3253 |
|
| Dihydromyricetin prevents cardiotoxicity and enhances anticancer activity induced by adriamycin |
|
https://doi.org/10.18632/oncotarget.2410
Hong Zhu, Peihua Luo, Yingying Fu, Jincheng Wang, Jiabin Dai, Jinjin Shao, Xiaochun Yang, Linlin Chang, Qinjie Weng, Bo Yang, and Qiaojun He
|
| 3254-3267 |
|
| MiR125b regulates epithelialmesenchymal transition via targeting Sema4C in paclitaxelresistant breast cancer cells |
|
https://doi.org/10.18632/oncotarget.3065
Qingling Yang, Yangyang Wang, Xiaohui Lu, Zunlan Zhao, Lihua Zhu, Sulian Chen, Qiong Wu, Changjie Chen, and Zhiwei Wang
|
| 3268-3279 |
|
| Biomolecular characterization of exosomes released from cancer stem cells: Possible implications for biomarker and treatment of cancer |
|
https://doi.org/10.18632/oncotarget.2462
Dhruv Kumar, Dwijendra Gupta, Sharmila Shankar, and Rakesh K. Srivastava
|
| 3280-3291 |
|
| MYC is a critical target of FBXW7 |
|
https://doi.org/10.18632/oncotarget.3203
Mai Sato, Ruth Rodriguez-Barrueco, Jiyang Yu, Catherine Do, Jose M. Silva, and Jean Gautier
|
| 3292-3305 |
|
| Overexpression of IFNinduced protein with tetratricopeptide repeats 3 IFIT3 in pancreatic cancer: cellular “pseudoinflammation†contributing to an aggressive phenotype |
|
https://doi.org/10.18632/oncotarget.2494
Hanno Niess, Peter Camaj, Ruth Mair, Andrea Renner, Yue Zhao, Carsten Jäckel, Peter J. Nelson, Karl-Walter Jauch, and Christiane J. Bruns
|
| 3306-3318 |
|
| In vivo treatment with epigenetic modulating agents induces transcriptional alterations associated with prognosis and immunomodulation in multiple myeloma |
|
https://doi.org/10.18632/oncotarget.3207
Ken Maes, Eva De Smedt, Alboukadel Kassambara, Dirk Hose, Anja Seckinger, Els Van Valckenborgh, Eline Menu, Bernard Klein, Karin Vanderkerken, Jérôme Moreaux, and Elke De Bruyne
|
| 3319-3334 |
|
| Prognostic and therapeutic impact of RPN2mediated tumor malignancy in nonsmallcell lung cancer |
|
https://doi.org/10.18632/oncotarget.2793
Yu Fujita, Shigehiro Yagishita, Fumitaka Takeshita, Yusuke Yamamoto, Kazuyoshi Kuwano, and Takahiro Ochiya
|
| 3335-3345 |
|
| Differential expression and prognostic value of the chemokine receptor CXCR4 in bronchopulmonary neuroendocrine neoplasms |
|
https://doi.org/10.18632/oncotarget.3242
Daniel Kaemmerer, Christiane Reimann, Elisa Specht, Ralph M. Wirtz, Manal Sayeg, Richard P. Baum, Stefan Schulz, and Amelie Lupp
|
| 3346-3358 |
|
| Mechanism of action and therapeutic efficacy of Aurora kinase B inhibition in MYC overexpressing medulloblastoma |
|
https://doi.org/10.18632/oncotarget.3245
Roberto Jose Diaz, Brian Golbourn, Claudia Faria, Daniel Picard, David Shih, Denis Raynaud, Michael Leadly, Danielle MacKenzie, Melissa Bryant, Matthew Bebenek, Christian A. Smith, Michael D. Taylor, Annie Huang, and James T. Rutka
|
| 3359-3374 |
|
| A Golgibased KDELRdependent signalling pathway controls extracellular matrix degradation |
|
https://doi.org/10.18632/oncotarget.3270
Carmen Ruggiero, Giorgia Fragassi, Mauro Grossi, Benedetta Picciani, Rosaria Di Martino, Mirco Capitani, Roberto Buccione, Alberto Luini, and Michele Sallese
|
| 3375-3393 |
|
| Combined inhibition of Chk1 and Wee1 as a new therapeutic strategy for mantle cell lymphoma |
|
https://doi.org/10.18632/oncotarget.2583
Rosaria Chilà , Alessandra Basana, Monica Lupi, Federica Guffanti, Eugenio Gaudio, Andrea Rinaldi, Luciano Cascione, Valentina Restelli, Chiara Tarantelli, Francesco Bertoni, Giovanna Damia, and Laura Carrassa
|
| 3394-3408 |
|
| FHIT lossinduced DNA damage creates optimal APOBEC substrates: Insights into APOBECmediated mutagenesis |
|
https://doi.org/10.18632/oncotarget.2636
Catherine E. Waters, Joshua C. Saldivar, Zaynab A. Amin, Morgan S. Schrock, and Kay Huebner
|
| 3409-3419 |
|
| Methylation of MGMT and ADAMTS14 in normal colon MUCOSA: biomarkers of a field defect for cancerization preferentially targeting elder AfricanAmericans |
|
https://doi.org/10.18632/oncotarget.2852
Sergio Alonso, Yuichi Dai, Kentaro Yamashita, Shina Horiuchi, Tomoko Dai, Akihiro Matsunaga, Rosa Sánchez-Muñoz, Cristina Bilbao-Sieyro, Juan Carlos DÃaz-Chico, Andrei V. Chernov, Alex Y. Strongin, and Manuel Perucho
|
| 3420-3431 |
|
| RMP predicts survival and adjuvant TACE response in hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.3092
Jian Zhang, Tian-Yi Jiang, Bei-Ge Jiang, Chun Yang, Ye-Xiong Tan, Ning Yang, Yu-Fei Pan, Zhi-Wen Ding, Guang-Zhen Yang, Meng-Chao Wu, Li-Wei Dong, and Hong-Yang Wang
|
| 3432-3442 |
|
| Oncogenes and tumor suppressor genes in squamous cell carcinoma of the tongue in young patients |
|
https://doi.org/10.18632/oncotarget.2850
Andreas Knopf, Justine Lempart, Murat Bas, Julia Slotta-Huspenina, Naglaa Mansour, and Marie Kristin Fritsche
|
| 3443-3451 |
|
| B7H1 and B7H3 are independent predictors of poor prognosis in patients with nonsmall cell lung cancer |
|
https://doi.org/10.18632/oncotarget.3097
Yixiang Mao, Wei Li, Kai Chen, Yufeng Xie, Qiang Liu, Min Yao, Weiming Duan, Xiumin Zhou, Rongrui Liang, and Min Tao
|
| 3452-3461 |
|
| Potential impact of human papilloma virus on survival of basaloid squamous carcinoma of the head and neck |
|
https://doi.org/10.18632/oncotarget.3062
Christian Jacobi, Isabelle Ayx, Kristin Fritsche, Guido Piontek, Dieter Hoffmann, Gregor Weirich, and Andreas Knopf
|
| 3462-3470 |
